DNA-analysis in hereditary cancer: The importance of a reliable family history;DNA-diagnostiek bij erfelijke kanker: Het belang van betrouwbare familiegegevens

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 2, 2005, Pages 57-60

  Kapma, S ^a   Leschot, N J ^a   Aalfs, C M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CASE REPORT; COLORECTAL CANCER; DNA DETERMINATION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MALE; OVARY CANCER; PATIENT COUNSELING;

ADULT; BREAST NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POPULATION SURVEILLANCE;

EID: 11344263841     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshieman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition. Cancer Res 1998;58:5248-57.
2. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
3. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:198-213.
4. Evans DG, Bulman M, Young K, Gokhale D, Lalloo F. Sensitivity of BKCA1/2 mutation testing in 466 breast/ovarian cancer families. J Med Genet 2003;40:e107.
5. Asperen CJ van, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, et al. Possible consequences of applying guidelines to healthy women with a family history of breast cancer. Eur J Hum Genet 2003;11:633-6.
6. Osorio A, de la Hoya M, Rodriguez-Lopez R, Martinez-Ramirez A, Cazorla A, Granizo JJ, et al. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 2002;99:305-9.
7. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994;73:643-51.
8. Asperen CJ van, Bock GH de, Horst F van der, Koning HJ de, Rutgers EJ. Screening op mammacarcinoom buiten het landelijke bevolkingsonderzoek, op grond van individuele risico-inschatting. Ned Tijdschr Geneeskd 2001;145:120-5.
9. Menko FH, Griffioen G, Wijnen JT, Tops CM, Fodde K, Vasen HF. Genetica van darmkanker. II. Erfelijke achtergrond van sporadische en familiaire darmkanker. Ned Tijdschr Geneeskd 1999;143:1207-11.
10. Oosterwijk JC, Sijmons RH, Menko FH, Chirus AM, Rookus MA. De kans op mammacarcinoom en samenhangende carcinomen bij een positieve familieanamnese. Ned Tijdschr Geneeskd 1995;139:423-8.
11. Bock GH de, Beusmans GHMI, Hinloopen R, Roelfsema WJ, Wiersma Tj. NHG-standaard Diagnostiek van mammacarcinoom. Huisarts Wet 2002;45:466-72.
12. Sijmons RH, Boonstra AE, Reefhuis J, Hordijk-Hos JM, Walle HE de, Oosterwijk JC, et al. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet 2000;8:181-6.
13. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyvenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet 2003;116A:11-9.
14. Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, Gritz EK. A social network analysis of communication about hereditary non-polyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 2003;12:304-13.
15. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996;14:1730-6.